Mechanistically, KCs can suppress the tumor-killing toxicity of CD8 + T cells via B7-H1/PD-1 interactions or mucin domain-containing molecule-3 (Tim-3)/galectin-9 signaling pathways in HCC [42, 43]. The gene discussed is TBCE; the disease is hepatocellular carcinoma.